Atlas Trials

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

Clinical trial NCT02240888 · COMPLETED

Trial details

NCT number
NCT02240888
Sponsor
Region Skane
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
RASLEVasculitisSclerodermaSjögrensSyndrome
Start date
2011-10-01
Primary completion
2017-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.